img

Global Low Molecular Weight Heparin Sodium Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Low Molecular Weight Heparin Sodium Market Research Report 2024

This report mainly studies low molecular weight heparin sodium market. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
According to Mr Accuracy reports new survey, global Low Molecular Weight Heparin Sodium market is projected to reach US$ 6020.7 million in 2029, increasing from US$ 3896 million in 2022, with the CAGR of 6.6% during the period of 2024 to 2029.
Factors such as increasing advantages of low molecular weight heparin overunfractionated heparin and increasing introduction of biosimilar low molecularweight heparin anticoagulants globally are expected to drive the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Low Molecular Weight Heparin Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutica
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Segment by Application


Medical
Research

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Low Molecular Weight Heparin Sodium report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Low Molecular Weight Heparin Sodium Market Overview
1.1 Product Overview and Scope of Low Molecular Weight Heparin Sodium
1.2 Low Molecular Weight Heparin Sodium Segment by Type
1.2.1 Global Low Molecular Weight Heparin Sodium Market Value Comparison by Type (2024-2034)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin Sodium Segment by Application
1.3.1 Global Low Molecular Weight Heparin Sodium Market Value by Application: (2024-2034)
1.3.2 Medical
1.3.3 Research
1.4 Global Low Molecular Weight Heparin Sodium Market Size Estimates and Forecasts
1.4.1 Global Low Molecular Weight Heparin Sodium Revenue 2018-2029
1.4.2 Global Low Molecular Weight Heparin Sodium Sales 2018-2029
1.4.3 Global Low Molecular Weight Heparin Sodium Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Low Molecular Weight Heparin Sodium Market Competition by Manufacturers
2.1 Global Low Molecular Weight Heparin Sodium Sales Market Share by Manufacturers (2018-2024)
2.2 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Low Molecular Weight Heparin Sodium Average Price by Manufacturers (2018-2024)
2.4 Global Low Molecular Weight Heparin Sodium Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Low Molecular Weight Heparin Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Low Molecular Weight Heparin Sodium, Product Type & Application
2.7 Low Molecular Weight Heparin Sodium Market Competitive Situation and Trends
2.7.1 Low Molecular Weight Heparin Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Low Molecular Weight Heparin Sodium Players Market Share by Revenue
2.7.3 Global Low Molecular Weight Heparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Low Molecular Weight Heparin Sodium Retrospective Market Scenario by Region
3.1 Global Low Molecular Weight Heparin Sodium Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Low Molecular Weight Heparin Sodium Global Low Molecular Weight Heparin Sodium Sales by Region: 2018-2029
3.2.1 Global Low Molecular Weight Heparin Sodium Sales by Region: 2018-2024
3.2.2 Global Low Molecular Weight Heparin Sodium Sales by Region: 2024-2029
3.3 Global Low Molecular Weight Heparin Sodium Global Low Molecular Weight Heparin Sodium Revenue by Region: 2018-2029
3.3.1 Global Low Molecular Weight Heparin Sodium Revenue by Region: 2018-2024
3.3.2 Global Low Molecular Weight Heparin Sodium Revenue by Region: 2024-2029
3.4 North America Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.4.1 North America Low Molecular Weight Heparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Low Molecular Weight Heparin Sodium Sales by Country (2018-2029)
3.4.3 North America Low Molecular Weight Heparin Sodium Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.5.1 Europe Low Molecular Weight Heparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Low Molecular Weight Heparin Sodium Sales by Country (2018-2029)
3.5.3 Europe Low Molecular Weight Heparin Sodium Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Low Molecular Weight Heparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Low Molecular Weight Heparin Sodium Sales by Country (2018-2029)
3.6.3 Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.7.1 Latin America Low Molecular Weight Heparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Low Molecular Weight Heparin Sodium Sales by Country (2018-2029)
3.7.3 Latin America Low Molecular Weight Heparin Sodium Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Low Molecular Weight Heparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2018-2029)
3.8.3 Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Low Molecular Weight Heparin Sodium Sales by Type (2018-2029)
4.1.1 Global Low Molecular Weight Heparin Sodium Sales by Type (2018-2024)
4.1.2 Global Low Molecular Weight Heparin Sodium Sales by Type (2024-2029)
4.1.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2018-2029)
4.2 Global Low Molecular Weight Heparin Sodium Revenue by Type (2018-2029)
4.2.1 Global Low Molecular Weight Heparin Sodium Revenue by Type (2018-2024)
4.2.2 Global Low Molecular Weight Heparin Sodium Revenue by Type (2024-2029)
4.2.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2018-2029)
4.3 Global Low Molecular Weight Heparin Sodium Price by Type (2018-2029)
5 Segment by Application
5.1 Global Low Molecular Weight Heparin Sodium Sales by Application (2018-2029)
5.1.1 Global Low Molecular Weight Heparin Sodium Sales by Application (2018-2024)
5.1.2 Global Low Molecular Weight Heparin Sodium Sales by Application (2024-2029)
5.1.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2018-2029)
5.2 Global Low Molecular Weight Heparin Sodium Revenue by Application (2018-2029)
5.2.1 Global Low Molecular Weight Heparin Sodium Revenue by Application (2018-2024)
5.2.2 Global Low Molecular Weight Heparin Sodium Revenue by Application (2024-2029)
5.2.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2018-2029)
5.3 Global Low Molecular Weight Heparin Sodium Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aspen
6.1.1 Aspen Corporation Information
6.1.2 Aspen Description and Business Overview
6.1.3 Aspen Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Aspen Low Molecular Weight Heparin Sodium Product Portfolio
6.1.5 Aspen Recent Developments/Updates
6.2 Sanofi-aventis
6.2.1 Sanofi-aventis Corporation Information
6.2.2 Sanofi-aventis Description and Business Overview
6.2.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sanofi-aventis Low Molecular Weight Heparin Sodium Product Portfolio
6.2.5 Sanofi-aventis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Pfizer Low Molecular Weight Heparin Sodium Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Opocrin
6.4.1 Opocrin Corporation Information
6.4.2 Opocrin Description and Business Overview
6.4.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Opocrin Low Molecular Weight Heparin Sodium Product Portfolio
6.4.5 Opocrin Recent Developments/Updates
6.5 CSBIO
6.5.1 CSBIO Corporation Information
6.5.2 CSBIO Description and Business Overview
6.5.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.5.4 CSBIO Low Molecular Weight Heparin Sodium Product Portfolio
6.5.5 CSBIO Recent Developments/Updates
6.6 Dongying Tiandong Pharmaceutica
6.6.1 Dongying Tiandong Pharmaceutica Corporation Information
6.6.2 Dongying Tiandong Pharmaceutica Description and Business Overview
6.6.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Portfolio
6.6.5 Dongying Tiandong Pharmaceutica Recent Developments/Updates
6.7 Changzhou Qianhong Bio-pharma
6.6.1 Changzhou Qianhong Bio-pharma Corporation Information
6.6.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.6.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Portfolio
6.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.8 Techdow
6.8.1 Techdow Corporation Information
6.8.2 Techdow Description and Business Overview
6.8.3 Techdow Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Techdow Low Molecular Weight Heparin Sodium Product Portfolio
6.8.5 Techdow Recent Developments/Updates
6.9 Yantai Dongcheng Pharmaceutical Group
6.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Yantai Dongcheng Pharmaceutical Group Description and Business Overview
6.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Portfolio
6.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Low Molecular Weight Heparin Sodium Industry Chain Analysis
7.2 Low Molecular Weight Heparin Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Low Molecular Weight Heparin Sodium Production Mode & Process
7.4 Low Molecular Weight Heparin Sodium Sales and Marketing
7.4.1 Low Molecular Weight Heparin Sodium Sales Channels
7.4.2 Low Molecular Weight Heparin Sodium Distributors
7.5 Low Molecular Weight Heparin Sodium Customers
8 Low Molecular Weight Heparin Sodium Market Dynamics
8.1 Low Molecular Weight Heparin Sodium Industry Trends
8.2 Low Molecular Weight Heparin Sodium Market Drivers
8.3 Low Molecular Weight Heparin Sodium Market Challenges
8.4 Low Molecular Weight Heparin Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Low Molecular Weight Heparin Sodium Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Low Molecular Weight Heparin Sodium Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Low Molecular Weight Heparin Sodium Market Competitive Situation by Manufacturers in 2022
Table 4. Global Low Molecular Weight Heparin Sodium Sales (K MT) of Key Manufacturers (2018-2024)
Table 5. Global Low Molecular Weight Heparin Sodium Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Low Molecular Weight Heparin Sodium Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Low Molecular Weight Heparin Sodium Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Low Molecular Weight Heparin Sodium Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Low Molecular Weight Heparin Sodium, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Low Molecular Weight Heparin Sodium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Low Molecular Weight Heparin Sodium, Product Type & Application
Table 12. Global Key Manufacturers of Low Molecular Weight Heparin Sodium, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Low Molecular Weight Heparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin Sodium as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Low Molecular Weight Heparin Sodium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Low Molecular Weight Heparin Sodium Sales by Region (2018-2024) & (K MT)
Table 18. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2018-2024)
Table 19. Global Low Molecular Weight Heparin Sodium Sales by Region (2024-2029) & (K MT)
Table 20. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2024-2029)
Table 21. Global Low Molecular Weight Heparin Sodium Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2018-2024)
Table 23. Global Low Molecular Weight Heparin Sodium Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2024-2029)
Table 25. North America Low Molecular Weight Heparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 27. North America Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 28. North America Low Molecular Weight Heparin Sodium Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Low Molecular Weight Heparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Low Molecular Weight Heparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 32. Europe Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 33. Europe Low Molecular Weight Heparin Sodium Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Low Molecular Weight Heparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Region (2018-2024) & (K MT)
Table 37. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Low Molecular Weight Heparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 42. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Low Molecular Weight Heparin Sodium Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Low Molecular Weight Heparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 47. Middle East & Africa Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Low Molecular Weight Heparin Sodium Sales (K MT) by Type (2018-2024)
Table 51. Global Low Molecular Weight Heparin Sodium Sales (K MT) by Type (2024-2029)
Table 52. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2018-2024)
Table 53. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2024-2029)
Table 54. Global Low Molecular Weight Heparin Sodium Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Low Molecular Weight Heparin Sodium Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2018-2024)
Table 57. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2024-2029)
Table 58. Global Low Molecular Weight Heparin Sodium Price (USD/MT) by Type (2018-2024)
Table 59. Global Low Molecular Weight Heparin Sodium Price (USD/MT) by Type (2024-2029)
Table 60. Global Low Molecular Weight Heparin Sodium Sales (K MT) by Application (2018-2024)
Table 61. Global Low Molecular Weight Heparin Sodium Sales (K MT) by Application (2024-2029)
Table 62. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2018-2024)
Table 63. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2024-2029)
Table 64. Global Low Molecular Weight Heparin Sodium Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Low Molecular Weight Heparin Sodium Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2018-2024)
Table 67. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2024-2029)
Table 68. Global Low Molecular Weight Heparin Sodium Price (USD/MT) by Application (2018-2024)
Table 69. Global Low Molecular Weight Heparin Sodium Price (USD/MT) by Application (2024-2029)
Table 70. Aspen Corporation Information
Table 71. Aspen Description and Business Overview
Table 72. Aspen Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. Aspen Low Molecular Weight Heparin Sodium Product
Table 74. Aspen Recent Developments/Updates
Table 75. Sanofi-aventis Corporation Information
Table 76. Sanofi-aventis Description and Business Overview
Table 77. Sanofi-aventis Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Sanofi-aventis Low Molecular Weight Heparin Sodium Product
Table 79. Sanofi-aventis Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Pfizer Low Molecular Weight Heparin Sodium Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Opocrin Corporation Information
Table 86. Opocrin Description and Business Overview
Table 87. Opocrin Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Opocrin Low Molecular Weight Heparin Sodium Product
Table 89. Opocrin Recent Developments/Updates
Table 90. CSBIO Corporation Information
Table 91. CSBIO Description and Business Overview
Table 92. CSBIO Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. CSBIO Low Molecular Weight Heparin Sodium Product
Table 94. CSBIO Recent Developments/Updates
Table 95. Dongying Tiandong Pharmaceutica Corporation Information
Table 96. Dongying Tiandong Pharmaceutica Description and Business Overview
Table 97. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product
Table 99. Dongying Tiandong Pharmaceutica Recent Developments/Updates
Table 100. Changzhou Qianhong Bio-pharma Corporation Information
Table 101. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 102. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product
Table 104. Changzhou Qianhong Bio-pharma Recent Developments/Updates
Table 105. Techdow Corporation Information
Table 106. Techdow Description and Business Overview
Table 107. Techdow Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. Techdow Low Molecular Weight Heparin Sodium Product
Table 109. Techdow Recent Developments/Updates
Table 110. Yantai Dongcheng Pharmaceutical Group Corporation Information
Table 111. Yantai Dongcheng Pharmaceutical Group Description and Business Overview
Table 112. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product
Table 114. Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Low Molecular Weight Heparin Sodium Distributors List
Table 118. Low Molecular Weight Heparin Sodium Customers List
Table 119. Low Molecular Weight Heparin Sodium Market Trends
Table 120. Low Molecular Weight Heparin Sodium Market Drivers
Table 121. Low Molecular Weight Heparin Sodium Market Challenges
Table 122. Low Molecular Weight Heparin Sodium Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Low Molecular Weight Heparin Sodium
Figure 2. Global Low Molecular Weight Heparin Sodium Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Low Molecular Weight Heparin Sodium Market Share by Type in 2022 & 2029
Figure 4. Enoxaparin Product Picture
Figure 5. Dalteparin Product Picture
Figure 6. Tinzaparin Product Picture
Figure 7. Fraxiparine Product Picture
Figure 8. Global Low Molecular Weight Heparin Sodium Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Low Molecular Weight Heparin Sodium Market Share by Application in 2022 & 2029
Figure 10. Medical
Figure 11. Research
Figure 12. Global Low Molecular Weight Heparin Sodium Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Low Molecular Weight Heparin Sodium Market Size (2018-2029) & (US$ Million)
Figure 14. Global Low Molecular Weight Heparin Sodium Sales (2018-2029) & (K MT)
Figure 15. Global Low Molecular Weight Heparin Sodium Average Price (USD/MT) & (2018-2029)
Figure 16. Low Molecular Weight Heparin Sodium Report Years Considered
Figure 17. Low Molecular Weight Heparin Sodium Sales Share by Manufacturers in 2022
Figure 18. Global Low Molecular Weight Heparin Sodium Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Low Molecular Weight Heparin Sodium Players: Market Share by Revenue in 2022
Figure 20. Low Molecular Weight Heparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Low Molecular Weight Heparin Sodium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Low Molecular Weight Heparin Sodium Sales Market Share by Country (2018-2029)
Figure 23. North America Low Molecular Weight Heparin Sodium Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Country (2018-2029)
Figure 27. Europe Low Molecular Weight Heparin Sodium Revenue Market Share by Country (2018-2029)
Figure 28. Germany Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Low Molecular Weight Heparin Sodium Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2018-2029)
Figure 35. China Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Low Molecular Weight Heparin Sodium Sales Market Share by Country (2018-2029)
Figure 45. Latin America Low Molecular Weight Heparin Sodium Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Low Molecular Weight Heparin Sodium Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Low Molecular Weight Heparin Sodium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Low Molecular Weight Heparin Sodium by Type (2018-2029)
Figure 55. Global Revenue Market Share of Low Molecular Weight Heparin Sodium by Type (2018-2029)
Figure 56. Global Low Molecular Weight Heparin Sodium Price (USD/MT) by Type (2018-2029)
Figure 57. Global Sales Market Share of Low Molecular Weight Heparin Sodium by Application (2018-2029)
Figure 58. Global Revenue Market Share of Low Molecular Weight Heparin Sodium by Application (2018-2029)
Figure 59. Global Low Molecular Weight Heparin Sodium Price (USD/MT) by Application (2018-2029)
Figure 60. Low Molecular Weight Heparin Sodium Value Chain
Figure 61. Low Molecular Weight Heparin Sodium Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed